Dahyeon Son

Dahyeon Son

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 August 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
YCYoo Jin Choi
Yoo Jin Choi
MPMin Ji Park
Min Ji Park
YCYoungjin Cho
Youngjin Cho
JKJoonghee Kim
Joonghee Kim
ELEunkyoung Lee
Eunkyoung Lee
MSMoon-Seung Soh
Moon-Seung Soh
Background: Acute pulmonary embolism (PE) is a critical condition where the timely and accurate assessment of right ventricular (RV) dysfunction is important for patient management. Given the limited availability of echocardiography in emergency departments (EDs), an artificial intelligence (AI) application that can identify RV dysfunction from electrocardiograms (ECGs) could improve the treatment of acute PE. Methods: This retrospective study analyzed adult acute PE patients in an ED from January 2021 to December 2023. We evaluated a smartphone application which analyzes printed ECGs to generate digital biomarkers for various conditions, including RV dysfunction (QCG-RVDys). The biomarker’s performance was compared with that of cardiologists and emergency physicians. Results: Among 116 included patients, 35 (30.2%) were diagnosed with RV dysfunction. The QCG-RVDys score demonstrated significant effectiveness in identifying RV dysfunction, with a receiver operating characteristic–area under the curve (AUC) of 0.895 (95% CI, 0.829–0.960), surpassing traditional biomarkers such as Troponin I (AUC: 0.692, 95% CI: 0.536–0.847) and ProBNP (AUC: 0.655, 95% CI: 0.532–0.778). Binarized based on the Youden Index, QCG-RVDys achieved an AUC of 0.845 (95% CI: 0.778–0.911), with a sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of 91.2% (95% CI: 82.4–100%), 77.8% (95% CI: 69.1–86.4%), 63.3% (95% CI: 54.4–73.9%), and 95.5% (95% CI: 90.8–100%), respectively, significantly outperforming all the expert clinicians, with their AUCs ranging from 0.628 to 0.683. Conclusions: The application demonstrates promise in rapidly assessing RV dysfunction in acute PE patients. Its high NPV could streamline patient management, potentially reducing the reliance on echocardiography in emergency settings.

1 January 2025 in Yonsei Medical Journal
Verified
Journal Article
Open access
PDF file
JKJin Hee Kim
Jin Hee Kim
JJJae Yun Jung
Jae Yun Jung
JKJoonghee Kim
Joonghee Kim
YCYoungjin Cho
Youngjin Cho
ELEunkyoung Lee
Eunkyoung Lee
DSDahyeon Son
Dahyeon Son
Kim JH, et al. Yonsei Med J. 2024 Nov;66:e6. https://doi.org/10.3349/ymj.2024.0148

9 May 2024 in medRxiv
Verified
Preprint
Open access
PDF file
YCYoo Jin Choi
Yoo Jin Choi
MPMin Ji Park
Min Ji Park
YCYoungjin Cho
Youngjin Cho
JKJoonghee Kim
Joonghee Kim
ELEunkyoung Lee
Eunkyoung Lee
MSMoon-Seung Soh
Moon-Seung Soh
Background Acute pulmonary embolism (PE) is a critical condition where timely and accurate assessment of right ventricular (RV) dysfunction is important for patient management. Given the limited availability of echocardiography in emergency departments (EDs), an artificial intelligence (AI) application that can identify RV dysfunction from electrocardiograms (ECG) could improve the treatment of acute PE. Methods This retrospective study analyzed adult acute PE patients in an ED from January 2021 to December 2023. We evaluated a smartphone application which analyzes printed ECG to generate digital biomarkers for various conditions including RV dysfunction (QCG-RVDys). The biomarker’s performance was compared with that of cardiologists and emergency physicians. Results Among 116 included patients, 35 (30.2%) were diagnosed with RV dysfunction. The QCG-RVDys score demonstrated significant effectiveness in identifying RV dysfunction, with a receiver operating characteristic - area under the curve(AUC) of 0.895 (95% CI, 0.829-0.960), surpassing traditional biomarkers such as Troponin I (AUC: 0.692, 95% CI: 0.536-0.847) and ProBNP (AUC: 0.655, 95% CI: 0.532-0.778). Binarized based on the Youden Index, QCG-RVDys achieved an AUC of 0.845 (95% CI: 0.778-0.911), with sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of 91.2% (95% CI: 82.4-100%), 77.8% (95% CI: 69.1-86.4%), 63.3% (95% CI: 54.4-73.9%), and 95.5% (95% CI: 90.8-100%), respectively, significantly outperforming all the expert clinicians with their AUCs ranging from 0.628 to 0.683. Conclusion The application demonstrates promise in rapidly assessing RV dysfunction in acute PE patients. Its high NPV could streamline patient management, potentially reducing the reliance on echocardiography in emergency settings.